Movement Alert｜Twist Bioscience Corp Rises 5.04% in Regular Trading, AI-Powered Drug Discovery Narrative and Strong Revenue Guidance Continue to Lift Shares

Market Focus08-10 21:59

On August 10, Twist Bioscience Corp rose 5.04% in regular trading, trading at $121.80/share, with turnover of $50.58 million.

On the news front, the market continues to reassess the company's value driven by AI-empowered drug discovery. Twist Bioscience serves as the core \"Build-Test\" link in AI-driven Design-Build-Test-Learn workflows, handling high-throughput DNA synthesis and protein expression. The company has received order validation, with each iteration cycle driving customer repurchase of synthesis services, forming a positive feedback loop.

Additionally, the company previously raised its full-year revenue guidance to $456-$457 million and guided Q4 revenue to $123-$124 million, significantly above the FactSet consensus estimate of $117.4 million. In Q3, revenue reached $118.4 million, representing 23.2% year-over-year growth and exceeding analyst expectations of $114.5 million. The combination of robust growth trajectory and AI platform positioning continues to support the stock at elevated levels.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

1

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1118367482?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-10 21:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118367482","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Corp Rises 5.04% in Regular Trading, AI-Powered Drug Discovery Narrative and Strong Revenue Guidance Continue to Lift Shares","media":"Market Focus","content":"<p><p>On August 10, Twist Bioscience Corp rose 5.04% in regular trading, trading at $121.80/share, with turnover of $50.58 million.</p><p>On the news front, the market continues to reassess the company's value driven by AI-empowered drug discovery. Twist Bioscience serves as the core \\\"Build-Test\\\" link in AI-driven Design-Build-Test-Learn workflows, handling high-throughput DNA synthesis and protein expression. The company has received order validation, with each iteration cycle driving customer repurchase of synthesis services, forming a positive feedback loop.</p><p>Additionally, the company previously raised its full-year revenue guidance to $456-$457 million and guided Q4 revenue to $123-$124 million, significantly above the FactSet consensus estimate of $117.4 million. In Q3, revenue reached $118.4 million, representing 23.2% year-over-year growth and exceeding analyst expectations of $114.5 million. The combination of robust growth trajectory and AI platform positioning continues to support the stock at elevated levels.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Corp Rises 5.04% in Regular Trading, AI-Powered Drug Discovery Narrative and Strong Revenue Guidance Continue to Lift Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Corp Rises 5.04% in Regular Trading, AI-Powered Drug Discovery Narrative and Strong Revenue Guidance Continue to Lift Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-10 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 10, Twist Bioscience Corp rose 5.04% in regular trading, trading at $121.80/share, with turnover of $50.58 million.</p><p>On the news front, the market continues to reassess the company's value driven by AI-empowered drug discovery. Twist Bioscience serves as the core \\\"Build-Test\\\" link in AI-driven Design-Build-Test-Learn workflows, handling high-throughput DNA synthesis and protein expression. The company has received order validation, with each iteration cycle driving customer repurchase of synthesis services, forming a positive feedback loop.</p><p>Additionally, the company previously raised its full-year revenue guidance to $456-$457 million and guided Q4 revenue to $123-$124 million, significantly above the FactSet consensus estimate of $117.4 million. In Q3, revenue reached $118.4 million, representing 23.2% year-over-year growth and exceeding analyst expectations of $114.5 million. The combination of robust growth trajectory and AI platform positioning continues to support the stock at elevated levels.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1118367482","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118367482","pubTimestamp":1786370378,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 10, Twist Bioscience Corp rose 5.04% in regular trading, trading at $121.80/share, with turnover of $50.58 million.On the news front, the market continues to reassess the company's value...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"走势警报|Twist Bioscience Corp 在常规交易中上涨 5.04%，人工智能驱动的药物发现叙事和强劲的收入指引继续提振股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On August 10, Twist Bioscience Corp rose 5.04% in regular trading, trading at $121.80/share, with turnover of $50.58 million.On the news front, the market continues to reassess the company's value driven by AI-empowered drug discovery. Twist Bioscience serves as the core \\\"Build-Test\\\" link in AI-driven Design-Build-Test-Learn workflows, handling high-throughput DNA synthesis and protein expression. The company has received order validation, with each iteration cycle driving customer repurchase of synthesis services, forming a positive feedback loop.Additionally, the company previously raised its full-year revenue guidance to $456-$457 million and guided Q4 revenue to $123-$124 million, significantly above the FactSet consensus estimate of $117.4 million. In Q3, revenue reached $118.4 million, representing 23.2% year-over-year growth and exceeding analyst expectations of $114.5 million. The combination of robust growth trajectory and AI platform positioning continues to support the stock at elevated levels.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1118367482","isCrawlerRequest":true}